Literature DB >> 14605737

[Living donor liver transplantation].

K Tanaka1, S Kaihara.   

Abstract

Liver transplantation has evolved into the standard treatment for numerous endstage liver diseases. The increase of organ shortages led to living organ donation. In 1988 living donor liver transplantation (LDLT) was performed for the first time. Since then multiple difficulties associated with LDLT have been solved. In Kyoto we can look back on more than 900 transplantations since the initiation of our LDLT program in 1990, which is the oldest in Japan and the largest in the world. In the following we review our extensive experience with special focus on issues such as donor safety, results after LDLT, and potential complications in the recipient. Further, graft size mismatching, venous drainage from anterior segment of the right lobe graft, LDLT for hepatocellular carcinoma, AB0-incompatible transplantation, and recurrence of hepatitis C infection, which are still unsolved problems in LDLT, are described and future directions are indicated.

Entities:  

Mesh:

Year:  2003        PMID: 14605737     DOI: 10.1007/s00104-003-0744-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  57 in total

1.  Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

Authors:  T Bizollon; U Palazzo; C Ducerf; M Chevallier; M Elliott; J Baulieux; M Pouyet; C Trepo
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

2.  Living related liver transplantation in adults.

Authors:  S Kawasaki; M Makuuchi; H Matsunami; Y Hashikura; T Ikegami; Y Nakazawa; H Chisuwa; M Terada; S Miyagawa
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

3.  The association between hepatitis C infection and survival after orthotopic liver transplantation.

Authors:  Lisa M Forman; James D Lewis; Jesse A Berlin; Harold I Feldman; Michael R Lucey
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Physiologic considerations in major hepatic resections.

Authors:  H H Stone; W D Long; R B Smith; C D Haynes
Journal:  Am J Surg       Date:  1969-01       Impact factor: 2.565

5.  Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.

Authors:  Alberto Sánchez-Fueyo; Juan Carlos Restrepo; Llorenç Quintó; Miquel Bruguera; Luís Grande; José María Sánchez-Tapias; Joan Rodés; Antoni Rimola
Journal:  Transplantation       Date:  2002-01-15       Impact factor: 4.939

6.  Hepatic transplantation in children under 3 months of age: a single centre's experience.

Authors:  H Bonatti; P Muiesan; S Connelly; A Baker; G Mieli-Vergani; P Gibbs; N Heaton; M Rela
Journal:  J Pediatr Surg       Date:  1997-03       Impact factor: 2.545

7.  Adult-to-adult living donor liver transplantation using extended right lobe grafts.

Authors:  C M Lo; S T Fan; C L Liu; W I Wei; R J Lo; C L Lai; J K Chan; I O Ng; A Fung; J Wong
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

8.  Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

Authors:  Didier Samuel; Thierry Bizollon; Cyrille Feray; Bruno Roche; Si Nafa Si Ahmed; Catherine Lemonnier; Marielle Cohard; Michel Reynes; Michelle Chevallier; Christian Ducerf; Jacques Baulieux; Michael Geffner; Janice K Albrecht; Henri Bismuth; Christian Trepo
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

9.  Rat liver regeneration after 90% partial hepatectomy.

Authors:  J Gaub; J Iversen
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

10.  Long-term outcome of hepatitis C infection after liver transplantation.

Authors:  E J Gane; B C Portmann; N V Naoumov; H M Smith; J A Underhill; P T Donaldson; G Maertens; R Williams
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

View more
  1 in total

Review 1.  [Liver transplantation with living donor : current aspects, perspectives and significance in Germany].

Authors:  U Settmacher; A Bauschke; C Malessa; H Scheuerlein; J Zanow; F Rauchfuß
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.